Fungal Infections of Joints: the Current State of the Issue

Diseases caused by microscopic fungi (mycoses) have become an important clinical problem in recent decades. The importance of mycoses in rheumatology has increased significantly due to the active introduction of genetically engineered biological drugs into clinical practice, primarily tumor necrosis factor-α inhibitors and interleukin-17 inhibitors. In addition, a number of questions arise when establishing timely and correct diagnosis, as well as prescribing rational therapy in patients with mycotic septic arthritis, a disease that is quite difficult to treat. The most common etiological agents of fungal arthritis (FA) include Candida spp., Aspergillus fumigatus, Sporothrix schenckii, Coccidioides immitis, Blastomyces dermatitis, Cryptococcus neoformans, and Histoplasma capsulatum. This review examines the problems of diagnosis and treatment of FA associated with these pathogens.

1. Denning D. W. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024 Jul; 24 (7): e428–e438. doi: 10.1016/S1473-3099(23)00692-8.

2. Vallabhaneni S., Chiller T. M. Fungal infections and new biologic therapies. Curr Rheumatol Rep. 2016; 18 (5): 29. doi: 10.1007/s11926-016-0572-1.

3. Kong Y. X., Kong K. O. Fungal arthritis. Best Pract Res Clin Rheumatol. 2025 Mar; 39 (2): 102058. doi: 10.1016/j.berh.2025.102058.

4. Gamaletsou M. N., Rammaert B., Brause B., Bueno M. A., Dadwal S. S., Henry M. W. et al. Osteoarticular mycoses. Clin Microbiol Rev. 2022; 35 (4): e0008619. doi: 10.1128/cmr.00086-19.

5. Gamaletsou M. N., Rammaert B., Bueno M. A., Sipsas N. V., Moriyama B., Kontoyiannis D. P. et al. Candida arthritis: analysis of 112 pediatric and adult cases. Open Forum Infect Dis. 2015 Dec 23; 3 (1): ofv207. doi: 10.1093/ofid/ofv207.

6. Bariteau J. T., Waryasz G. R., McDonnell M., Fischer S. A., Hayda R. A., Born C. T. Fungal osteomyelitis and septic arthritis. J Am Acad Orthop Surg. 2014; 22 (6): 390–401. doi: 10.5435/JAAOS-22-06-390.

7. Pappas P. G., Kauffman C. A., Andes D. R., Clancy C. J., Marr K. A., Ostrosky-Zeichner L. et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the infectious diseases society of America. Clin Infect Dis. 2016; 62 (4): e1–50. doi: 10.1093/cid/civ933.

8. Kumar M., Thilak J., Zahoor A., Jyothi A. Septic arthritis due to tubercular and Aspergillus co-infection. Indian J Orthop. 2016; 50 (3): 327–30. doi: 10.4103/0019-5413.181783.

9. Tiwari V., Khatri K., Khan S. A., Nath D. Disseminated Aspergillus flavus following septic arthritis in an immunocompetent patient: a case report. BMC Res Notes. 2014; 7: 709. doi: 10.1186/1756-0500-7-709.

10. Patel A. J., Gattuso P., Reddy V. B. Diagnosis of blastomycosis in surgical pathology and cytopathology: correlation with microbiologic culture. Am J Surg Pathol. 2010; 34 (2): 256–61. doi: 10.1097/PAS.0b013e3181ca48a5. PMID: 20090507.

11. Chapman S. W., Dismukes W. E., Proia L. A., Bradsher R. W., Pappas P. G., Threlkeld M. G. et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46 (12): 1801–12. doi: 10.1086/588300.

12. Oppenheimer M., Embil J. M., Black B., Wiebe L., Limerick B., MacDonald K., Trepman E. Blastomycosis of bones and joints. South Med J. 2007; 100 (6): 570–8. doi: 10.1097/SMJ.0b013e3180487a92.

13. Cuéllar M. L., Silveira L. H., Citera G., Cabrera G. E., Valle R. Other fungal arthritides. Rheum Dis Clin North Am. 1993; 19 (2): 439–55.

14. Donovan F. M., Ampel N. M., Thompson G. R. 3rd. Coccidioidomycosis. Infect Dis Clin North Am. 2025; 39 (1): 183–197. doi: 10.1016/j.idc.2024.11.012.

15. Cuéllar M. L., Silveira L. H., Espinoza L. R. Fungal arthritis. Ann Rheum Dis. 1992; 51 (5): 690–697. doi: 10.1136/ard.51.5.690.

16. Mishra A., Juneja D. Fungal arthritis: A challenging clinical entity. World J Orthop. 2023; 14 (2): 55–63. doi: 10.5312/wjo.v14.i2.55.

17. Adam R. D., Elliott S. P., Taljanovic M. S. The spectrum and presentation of disseminated coccidioidomycosis. Am J Med. 2009; 122 (8): 770–777. doi: 10.1016/j.amjmed.2008.12.024.

18. Lund P. J., Chan K. M., Unger E. C., Galgiani T. N., Pitt M. J. Magnetic resonance imaging in coccidioidal arthritis. Skeletal Radiol. 1996; 25 (7): 661–665. doi: 10.1007/s002560050154.

19. Galgiani J. N., Ampel N. M., Blair J. E., Catanzaro A., Geertsma F., Hoover S. E. et al. 2016 Infectious diseases society of America (IDSA) Clinical Practice Guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016; 63 (6): e112–46. doi: 10.1093/cid/ciw360.

20. Kohli R., Hadley S. Fungal arthritis and osteomyelitis. Infect Dis Clin North Am. 2005; 19 (4): 831–851. doi: 10.1016/j.idc.2005.08.004.

21. Wheat L. J., Kohler R. B., Tewari R. P. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med. 1986; 314 (2): 83–88. doi: 10.1056/NEJM198601093140205.

22. Yacobucci G. N., Santilli M. D. Sporotrichosis of the knee. A case report. Orthopedics. 1986; 9 (3): 387–90. doi: 10.3928/0147-7447-19860301-11.

23. Kauffman C. A., Hajjeh R., Chapman S. W. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis. 2000; 30 (4): 684–7. doi: 10.1086/313751.

24. Perfect J. R., Dismukes W. E., Dromer F., Goldman D. L., Graybill J. R., Hamill R. J. et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010; 50 (3): 291–322. doi: 10.1086/649858.